Prediction of Response to IUCD Associated Menorrhagia Using Doppler

NCT03794895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2019-01-07

No results posted yet for this study

Summary

Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia

Conditions

  • Women's Health: Amenorrhea/Dysmenorrhea

Interventions

DEVICE

Doppler

Doing doppler for women having IUCD associated menorrhagia

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Yasmine Es Ismail, Bachelor · Ain Shams University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-05-01
Completion
2018-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03794895 on ClinicalTrials.gov